Expert Review of Clinical Immunology

期刊简介：Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Articles focus on the following key areas:• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines• Performance and benefits of newly approved therapeutic agents• New diagnostic approaches• Screening and patient stratification• Pharmacoeconomic studies• New therapeutic indications for existing therapies• Adverse effects, occurrence and reduction• Prospects for medicines in late-stage trials approaching regulatory approval• Novel treatment strategies• Epidemiological studies• Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

【译文】《临床免疫学专家评论》（ISSN 1744-666X）提供关于临床免疫学中新治疗和诊断方法表现的专家分析和评论。国际编辑顾问小组的成员是各自领域的尖端专家。该小组与我们的专业编辑团队合作，确定最重要的和最热门的评论主题以及最合适的专家来提供评论和分析。所有文章都经过严格的同行评审，完成的评论为临床免疫学决策提供了基本贡献。文章重点关注以下关键领域：特定免疫学疾病的药物治疗概述，强调最佳治疗和新型药物的前景；新批准治疗药物的性能和益处；新的诊断方法；筛查和患者分层；药物经济学研究；现有治疗的新治疗指征；不良反应、发生和减少；接近监管批准的晚期试验药物的前景；新颖的治疗策略；流行病学研究；治疗指南的评论和比较。主题包括感染和免疫、炎症、宿主防御机制、先天性免疫缺陷和获得性免疫缺陷、过敏性休克和过敏、系统性免疫疾病、器官特异性炎症疾病、移植免疫学、内分泌学和糖尿病、癌症免疫学、神经免疫学和血液疾病。